Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

Bond, David J

Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). [electronic resource] - Journal of affective disorders Jul 2010 - 108-17 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1573-2517

10.1016/j.jad.2009.10.023 doi


Adult
Antimanic Agents--adverse effects
Antipsychotic Agents--adverse effects
Benzodiazepines--adverse effects
Bipolar Disorder--blood
Blood Glucose--metabolism
Body Mass Index
Cholesterol--blood
Dibenzothiazepines--adverse effects
Female
Follow-Up Studies
Humans
Insulin--blood
Lithium Carbonate--adverse effects
Male
Obesity--blood
Olanzapine
Overweight--blood
Prospective Studies
Quetiapine Fumarate
Risperidone--adverse effects
Triglycerides--blood
Valproic Acid--adverse effects
Weight Gain--drug effects
Young Adult